Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor

Publié en février 2023 European Journal of Medicinal Chemistry

Reduced Intestinal Inflammation With Lumacaftor/Ivacaftor in Adolescents With Cystic Fibrosis

European Journal of Medicinal Chemistry

Publication précédente

Dietary intake assessment in children with cystic fibrosis using 3-day food diaries: a single-centre study

European Journal of Medicinal Chemistry

Publication suivante

Auteurs

Martina De Pascale
Lukas Bissegger
Chiara Tarantelli
Florent Beaufils
Alessandro Prescimone
Hayget Mohamed Seid Hedad
Omar Kayali
Clara Orbegozo
Luka Raguž
Thorsten Schaefer
Paul Hebeisen
Francesco Bertoni
Matthias P. Wymann
Chiara Borsari